Cybin (CBOE:HELP) Stock Price Down 6.3% – What’s Next?

Cybin Inc (CBOE:HELP)’s stock price fell 6.3% during mid-day trading on Thursday . The company traded as low as C$5.37 and last traded at C$5.38. 771,245 shares were traded during trading, The stock had previously closed at C$5.74.

Cybin Price Performance

Cybin Company Profile

Cybin (TSE: CYBN) is a clinical-stage biotechnology company focused on developing psychedelic-inspired therapeutics for the treatment of mental health disorders. The company pursues drug development programs that combine novel small-molecule compounds with proprietary formulation and delivery technologies, with the goal of producing standardized, scalable treatment options for conditions such as depression, anxiety and substance use disorders.

Cybin’s activities include preclinical research, formulation development, and conduct of Phase 1 and later-stage clinical trials to evaluate safety, tolerability and therapeutic effect.